Who invested in NovalGen

6 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Follow NovalGen and see its new rounds in your feed.Start following

Funding summaryUpdated 31 Oct 2026

$15Mraised across 6 rounds since 2021, from 6 sources

$2.8MSeries A$7.8MSeries A$1.2MSeries A$2.0MRound$806KRound$134KRound

Latest round: Round, $134KJan 2026
Biggest round: $7.8MSeries A · Aug 2022
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20222023202420252026

$2.8MSeries A$7.8MSeries A$1.2MSeries A$2.0MRound$806KRound$134KRound

First round: Series A, $2.8M
Biggest round: $7.8M
Usual gap between rounds: 6 months

The rounds

Jan 2026
Round$134K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Aug 2025
Round$806K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Feb 2025
Round$2.0M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Nov 2024
Series A$1.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Aug 2022
Series A$7.8M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Sept 2021
Series A$2.8M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

NovalGen filed 25 raises, $15M in all. Filings say how much was sold and to how many investors; they never name the investors.

Jan 2026$134KUK share allotment
Oct 2025$133KUK share allotment
Oct 2025$134KUK share allotment
Sept 2025$169KUK share allotment
Sept 2025$169KUK share allotment
Aug 2025$202KUK share allotment
Jun 2025$343KUK share allotment
May 2025$539KUK share allotment
Apr 2025$401KUK share allotment
Mar 2025$259KUK share allotment
Feb 2025$504KUK share allotment
Nov 2024$1.2MUK share allotment
Jul 2023$412KUK share allotment
Jun 2023$410KUK share allotment
May 2023$498KUK share allotment
May 2023$398KUK share allotment
Mar 2023$392KUK share allotment
Feb 2023$598KUK share allotment
Dec 2022$872KUK share allotment
Nov 2022$850KUK share allotment
Oct 2022$810KUK share allotment
Sept 2022$823KUK share allotment
Aug 2022$868KUK share allotment
Aug 2022$902KUK share allotment
Sept 2021$2.8MUK share allotment

Founders and team

From NovalGen's own website: 1 founder, 12 on the team.

Professor Amit NathwaniFounder & CEO

Dr Kieran O’DonovanCOO & CTO
Dr David GrangerVP R&D
Alexander BochesFinance Director
Bharat ThakrarDirector
Dr Laurent FischerChairman
Dr Simon GoldmanDirector
Dr Vincent MuczynskiDirector Biology
Nitin ShahFinance Director
Professor David VenablesDirector
Professor Mike OwenDirector
Samit HathiDirector
Scott ClarkeDirector

Also claim to have backed them

This firm lists NovalGen as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.